NU 664C Family Psychiatric Mental Health I Exam 1 Actual
2026/2027 - 100% Verified | Detailed Rationales - Pass
Guaranteed - A+ Graded
NU 664C Family Psychiatric Mental Health I Exam 1 2026-2027 QUESTIONS AND ANSWERS ALREADY
GRADED A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam prep document for NU 664C Family Psychiatric Mental Health I Exam 1
contains 250 verified questions with detailed rationales. Designed to ensure a thorough understanding
of psychiatric mental health nursing principles, this resource covers key topics including therapeutic
communication, psychopharmacology, and family therapy. Each question is aligned with the latest
2026/2027 curriculum guidelines, providing a reliable study tool for achieving a top grade. With a pass
guarantee, this document is essential for students seeking to excel in their psychiatric mental health
nursing exam.
Abstract:
This document serves as a definitive study resource for NU 664C Family Psychiatric Mental Health I Exam 1,
offering 250 meticulously verified questions that mirror the actual exam format. Each question is accompanied by
detailed rationales that explain the correct answer and address common misconceptions, facilitating deep
learning. The content spans essential areas such as therapeutic communication, psychopharmacology, family
therapy, and ethical practice, all aligned with the 2026/2027 academic standards. By integrating evidence-based
practice and current guidelines, this resource ensures students are well-prepared to achieve a superior grade. The
pass guarantee underscores the confidence in the material's accuracy and comprehensiveness. Ideal for both initial
study and final review, this document is a must-have for nursing students specializing in psychiatric mental health.
Content Area Overview:
Content Area Questions Key Topics Weight
Therapeutic Communication & 1-50 Active listening, empathy, open-ended 20%
Interviewing questions, reflection, silence
Psychopharmacology 51-100 Antidepressants, antipsychotics, mood 20%
stabilizers, anxiolytics, side effects
Family Therapy & Systems 101-150 Family dynamics, genograms, structural 20%
Theory therapy, strategic therapy, communication
patterns
Assessment & Diagnosis 151-200 Mental status exam, risk assessment, 20%
DSM-5-TR criteria, differential diagnosis
Ethical, Legal, & Cultural 201-250 Informed consent, confidentiality, 20%
Considerations mandatory reporting, cultural competence,
ethical dilemmas
Page 1
,Q1. A patient with treatment-resistant depression has failed adequate trials of two different SSRIs
and one SNRI. Which augmentation strategy is most supported by evidence for achieving
remission?
A. Add aripiprazole to the current SSRI
B. Switch to a monoamine oxidase inhibitor (MAOI) monotherapy
C. Add buspirone to the current SNRI
D. Augment with lithium carbonate
Correct Answer: A. Add aripiprazole to the current SSRI
Rationale: Aripiprazole is FDA-approved for augmentation in major depressive disorder and has strong
evidence from STAR*D and subsequent trials. MAOIs are reserved for later lines due to dietary
restrictions and safety concerns. Buspirone has modest evidence. Lithium augmentation is effective but
less studied in this context and requires monitoring.
Why Wrong:
B - MAOIs are typically reserved for patients who have failed multiple other classes due to safety
risks and dietary restrictions.
C - Buspirone augmentation has only modest efficacy and is not considered first-line after two failed
antidepressants.
D - Lithium augmentation is effective but is not the most evidence-supported option compared to
atypical antipsychotics in this scenario.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 14, 32
Q2. Which finding on mental status examination is most consistent with a diagnosis of generalized
anxiety disorder (GAD) rather than major depressive disorder (MDD)?
A. Depressed mood with anhedonia
B. Muscle tension and easy fatigability
C. Suicidal ideation with a plan
D. Psychomotor retardation
Correct Answer: B. Muscle tension and easy fatigability
Rationale: Muscle tension and easy fatigability are core features of GAD per DSM-5-TR, reflecting
chronic hyperarousal. Depressed mood and anhedonia are hallmark symptoms of MDD. Suicidal ideation
is more common in MDD. Psychomotor retardation is typical of MDD.
Why Wrong:
A - Depressed mood and anhedonia are core symptoms of MDD, not GAD.
C - Suicidal ideation with a plan is more characteristic of MDD, not GAD.
D - Psychomotor retardation is a typical symptom of MDD, not GAD.
Reference: American Psychiatric Association. (2022). DSM-5-TR. GAD and MDD criteria.
Page 2
,Q3. A patient with bipolar I disorder is stabilized on lithium but develops polyuria and polydipsia.
Which mechanism explains these adverse effects?
A. Inhibition of antidiuretic hormone (ADH) release from the posterior pituitary
B. Nephrogenic diabetes insipidus due to resistance to ADH at the collecting duct
C. Direct osmotic diuresis from lithium-induced hyperglycemia
D. Increased renal blood flow leading to glomerular hyperfiltration
Correct Answer: B. Nephrogenic diabetes insipidus due to resistance to ADH at the collecting duct
Rationale: Lithium accumulates in collecting duct cells and interferes with ADH-mediated water
reabsorption, causing nephrogenic diabetes insipidus. This is characterized by polyuria and polydipsia.
Lithium does not inhibit ADH release (central DI) nor cause hyperglycemia or increased renal blood
flow.
Why Wrong:
A - Lithium does not inhibit ADH release; it causes resistance to ADH at the kidney.
C - Lithium does not typically cause hyperglycemia; polyuria is due to ADH resistance.
D - Lithium does not increase renal blood flow; it directly affects collecting duct function.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 29
Q4. A patient with schizophrenia has persistent negative symptoms despite adequate antipsychotic
therapy. Which intervention is most likely to improve negative symptoms?
A. Increase the current antipsychotic dose to the maximum tolerated
B. Switch from haloperidol to clozapine
C. Add a second-generation antipsychotic to the current regimen
D. Initiate cognitive behavioral therapy (CBT) for psychosis
Correct Answer: D. Initiate cognitive behavioral therapy (CBT) for psychosis
Rationale: Negative symptoms are often resistant to antipsychotic medications. CBT for psychosis has
shown moderate evidence for improving negative symptoms by targeting apathy, social withdrawal, and
cognitive distortions. Increasing dose or adding another antipsychotic may worsen side effects without
benefit. Clozapine is primarily for treatment-resistant positive symptoms.
Why Wrong:
A - Increasing dose may worsen side effects and does not reliably improve negative symptoms.
B - Clozapine is indicated for treatment-resistant positive symptoms, not primarily for negative
symptoms.
C - Adding another antipsychotic increases side effect burden without clear evidence for negative
symptoms.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 30; APA Practice
Guideline for Schizophrenia (2021)
Page 3
, Q5. A patient with panic disorder is started on sertraline. Which instruction is most important to
include when initiating therapy?
A. Take the medication on an empty stomach to enhance absorption
B. Expect immediate relief of panic symptoms within the first week
C. Report any increase in anxiety or panic attacks during the first few weeks
D. Avoid all foods containing tyramine
Correct Answer: C. Report any increase in anxiety or panic attacks during the first few weeks
Rationale: SSRIs can cause an initial worsening of anxiety and panic attacks due to increased
serotonergic tone. Patients must be warned and monitored. Sertraline can be taken with or without food.
Therapeutic benefit takes 2-4 weeks. Tyramine restriction is for MAOIs, not SSRIs.
Why Wrong:
A - Sertraline can be taken with or without food; absorption is not significantly affected.
B - SSRIs have a delayed onset of 2-4 weeks; immediate relief is not expected.
D - Tyramine restriction is required only with MAOIs, not SSRIs.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 14
Q6. Which of the following best distinguishes obsessive-compulsive disorder (OCD) from
obsessive-compulsive personality disorder (OCPD)?
A. Presence of true obsessions and compulsions that are ego-dystonic
B. Preoccupation with orderliness and perfectionism
C. Onset in early adulthood
D. Limited insight into the irrationality of behaviors
Correct Answer: A. Presence of true obsessions and compulsions that are ego-dystonic
Rationale: OCD is characterized by ego-dystonic obsessions and compulsions that cause distress,
whereas OCPD involves ego-syntonic traits of perfectionism and control. Both can involve orderliness,
but the key distinction is the ego-dystonic nature of symptoms in OCD. Onset and insight are not
definitive.
Why Wrong:
B - Orderliness and perfectionism are more characteristic of OCPD, not distinctive for OCD.
C - Onset in early adulthood can occur in both disorders and is not distinguishing.
D - Limited insight can occur in both, though more common in OCD; not definitive.
Reference: American Psychiatric Association. (2022). DSM-5-TR. OCD and OCPD criteria.
Page 4
2026/2027 - 100% Verified | Detailed Rationales - Pass
Guaranteed - A+ Graded
NU 664C Family Psychiatric Mental Health I Exam 1 2026-2027 QUESTIONS AND ANSWERS ALREADY
GRADED A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam prep document for NU 664C Family Psychiatric Mental Health I Exam 1
contains 250 verified questions with detailed rationales. Designed to ensure a thorough understanding
of psychiatric mental health nursing principles, this resource covers key topics including therapeutic
communication, psychopharmacology, and family therapy. Each question is aligned with the latest
2026/2027 curriculum guidelines, providing a reliable study tool for achieving a top grade. With a pass
guarantee, this document is essential for students seeking to excel in their psychiatric mental health
nursing exam.
Abstract:
This document serves as a definitive study resource for NU 664C Family Psychiatric Mental Health I Exam 1,
offering 250 meticulously verified questions that mirror the actual exam format. Each question is accompanied by
detailed rationales that explain the correct answer and address common misconceptions, facilitating deep
learning. The content spans essential areas such as therapeutic communication, psychopharmacology, family
therapy, and ethical practice, all aligned with the 2026/2027 academic standards. By integrating evidence-based
practice and current guidelines, this resource ensures students are well-prepared to achieve a superior grade. The
pass guarantee underscores the confidence in the material's accuracy and comprehensiveness. Ideal for both initial
study and final review, this document is a must-have for nursing students specializing in psychiatric mental health.
Content Area Overview:
Content Area Questions Key Topics Weight
Therapeutic Communication & 1-50 Active listening, empathy, open-ended 20%
Interviewing questions, reflection, silence
Psychopharmacology 51-100 Antidepressants, antipsychotics, mood 20%
stabilizers, anxiolytics, side effects
Family Therapy & Systems 101-150 Family dynamics, genograms, structural 20%
Theory therapy, strategic therapy, communication
patterns
Assessment & Diagnosis 151-200 Mental status exam, risk assessment, 20%
DSM-5-TR criteria, differential diagnosis
Ethical, Legal, & Cultural 201-250 Informed consent, confidentiality, 20%
Considerations mandatory reporting, cultural competence,
ethical dilemmas
Page 1
,Q1. A patient with treatment-resistant depression has failed adequate trials of two different SSRIs
and one SNRI. Which augmentation strategy is most supported by evidence for achieving
remission?
A. Add aripiprazole to the current SSRI
B. Switch to a monoamine oxidase inhibitor (MAOI) monotherapy
C. Add buspirone to the current SNRI
D. Augment with lithium carbonate
Correct Answer: A. Add aripiprazole to the current SSRI
Rationale: Aripiprazole is FDA-approved for augmentation in major depressive disorder and has strong
evidence from STAR*D and subsequent trials. MAOIs are reserved for later lines due to dietary
restrictions and safety concerns. Buspirone has modest evidence. Lithium augmentation is effective but
less studied in this context and requires monitoring.
Why Wrong:
B - MAOIs are typically reserved for patients who have failed multiple other classes due to safety
risks and dietary restrictions.
C - Buspirone augmentation has only modest efficacy and is not considered first-line after two failed
antidepressants.
D - Lithium augmentation is effective but is not the most evidence-supported option compared to
atypical antipsychotics in this scenario.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 14, 32
Q2. Which finding on mental status examination is most consistent with a diagnosis of generalized
anxiety disorder (GAD) rather than major depressive disorder (MDD)?
A. Depressed mood with anhedonia
B. Muscle tension and easy fatigability
C. Suicidal ideation with a plan
D. Psychomotor retardation
Correct Answer: B. Muscle tension and easy fatigability
Rationale: Muscle tension and easy fatigability are core features of GAD per DSM-5-TR, reflecting
chronic hyperarousal. Depressed mood and anhedonia are hallmark symptoms of MDD. Suicidal ideation
is more common in MDD. Psychomotor retardation is typical of MDD.
Why Wrong:
A - Depressed mood and anhedonia are core symptoms of MDD, not GAD.
C - Suicidal ideation with a plan is more characteristic of MDD, not GAD.
D - Psychomotor retardation is a typical symptom of MDD, not GAD.
Reference: American Psychiatric Association. (2022). DSM-5-TR. GAD and MDD criteria.
Page 2
,Q3. A patient with bipolar I disorder is stabilized on lithium but develops polyuria and polydipsia.
Which mechanism explains these adverse effects?
A. Inhibition of antidiuretic hormone (ADH) release from the posterior pituitary
B. Nephrogenic diabetes insipidus due to resistance to ADH at the collecting duct
C. Direct osmotic diuresis from lithium-induced hyperglycemia
D. Increased renal blood flow leading to glomerular hyperfiltration
Correct Answer: B. Nephrogenic diabetes insipidus due to resistance to ADH at the collecting duct
Rationale: Lithium accumulates in collecting duct cells and interferes with ADH-mediated water
reabsorption, causing nephrogenic diabetes insipidus. This is characterized by polyuria and polydipsia.
Lithium does not inhibit ADH release (central DI) nor cause hyperglycemia or increased renal blood
flow.
Why Wrong:
A - Lithium does not inhibit ADH release; it causes resistance to ADH at the kidney.
C - Lithium does not typically cause hyperglycemia; polyuria is due to ADH resistance.
D - Lithium does not increase renal blood flow; it directly affects collecting duct function.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 29
Q4. A patient with schizophrenia has persistent negative symptoms despite adequate antipsychotic
therapy. Which intervention is most likely to improve negative symptoms?
A. Increase the current antipsychotic dose to the maximum tolerated
B. Switch from haloperidol to clozapine
C. Add a second-generation antipsychotic to the current regimen
D. Initiate cognitive behavioral therapy (CBT) for psychosis
Correct Answer: D. Initiate cognitive behavioral therapy (CBT) for psychosis
Rationale: Negative symptoms are often resistant to antipsychotic medications. CBT for psychosis has
shown moderate evidence for improving negative symptoms by targeting apathy, social withdrawal, and
cognitive distortions. Increasing dose or adding another antipsychotic may worsen side effects without
benefit. Clozapine is primarily for treatment-resistant positive symptoms.
Why Wrong:
A - Increasing dose may worsen side effects and does not reliably improve negative symptoms.
B - Clozapine is indicated for treatment-resistant positive symptoms, not primarily for negative
symptoms.
C - Adding another antipsychotic increases side effect burden without clear evidence for negative
symptoms.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 30; APA Practice
Guideline for Schizophrenia (2021)
Page 3
, Q5. A patient with panic disorder is started on sertraline. Which instruction is most important to
include when initiating therapy?
A. Take the medication on an empty stomach to enhance absorption
B. Expect immediate relief of panic symptoms within the first week
C. Report any increase in anxiety or panic attacks during the first few weeks
D. Avoid all foods containing tyramine
Correct Answer: C. Report any increase in anxiety or panic attacks during the first few weeks
Rationale: SSRIs can cause an initial worsening of anxiety and panic attacks due to increased
serotonergic tone. Patients must be warned and monitored. Sertraline can be taken with or without food.
Therapeutic benefit takes 2-4 weeks. Tyramine restriction is for MAOIs, not SSRIs.
Why Wrong:
A - Sertraline can be taken with or without food; absorption is not significantly affected.
B - SSRIs have a delayed onset of 2-4 weeks; immediate relief is not expected.
D - Tyramine restriction is required only with MAOIs, not SSRIs.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 14
Q6. Which of the following best distinguishes obsessive-compulsive disorder (OCD) from
obsessive-compulsive personality disorder (OCPD)?
A. Presence of true obsessions and compulsions that are ego-dystonic
B. Preoccupation with orderliness and perfectionism
C. Onset in early adulthood
D. Limited insight into the irrationality of behaviors
Correct Answer: A. Presence of true obsessions and compulsions that are ego-dystonic
Rationale: OCD is characterized by ego-dystonic obsessions and compulsions that cause distress,
whereas OCPD involves ego-syntonic traits of perfectionism and control. Both can involve orderliness,
but the key distinction is the ego-dystonic nature of symptoms in OCD. Onset and insight are not
definitive.
Why Wrong:
B - Orderliness and perfectionism are more characteristic of OCPD, not distinctive for OCD.
C - Onset in early adulthood can occur in both disorders and is not distinguishing.
D - Limited insight can occur in both, though more common in OCD; not definitive.
Reference: American Psychiatric Association. (2022). DSM-5-TR. OCD and OCPD criteria.
Page 4
